Tvashtr Biotech
We are Tvashtr Biotech Private Limited, an India-based Biotech start-up focusing on bridging the gap from eliminating laboratory dependency to developing novel, rapid, portable, easy-to-use and scalable technologies.



Gaps in Allergy Diagnosis
With over 400 million people suffering from allergies globally, yet 70% of them undiagnosed, we’re here to change that!
Recurring High Costs
Traditional tests are costly ($300–$1,000) in a $1.3B industry
Lack of adaptable technologies!
The unavailability of lab-accurate easy-to-use, rapid and portable devices.
Time-consuming Process
Requires specialized lab infrastructure, and takes several days to process and deliver results
Inconvenience to users
Methods such as skin-prick testing and patch-based testing used often cause a lot of discomfort to the user
​But can this all be done at your convenience anywhere, with lab-grade accuracy, without the doctor's interference, and with the consultation of post-test support. You should be able to take this decision into your own hands, right?
Prevalence of Food Allergies in USA
-
At least 26 million adults have food allergies, according to a 2019 joint study funded in part by the National Institute of Allergy and Infectious Disease. (Link)
-
45.3% of those with food allergies are allergic to multiple foods. (Link)
-
42.3% of children with food allergies have experienced a severe reaction. (Link)​
-
19% of children with food allergies report an emergency department visit due to food allergies in the previous year (42% report at last one previous emergency department visit due to food allergies) (Link)
-
Childhood food allergies alone cost the United States $24.8 billion annually. (Link)
-
​The per child cost is $4,184​​
-
Direct medical costs are $4.3 billion
-
​Costs that families are responsible for totaled $20.5 billion, which includes doctor and emergency department visits, hospitalizations, out-of-pocket expenses, loss of job productivity, and specialty foods
-
​
.png)
IMPACT!
US Market
50M+
People Affected with Food Allergies annually
47%
affected adults and children with multiple Food allergies
$1.3Bn
Market Size(TAM)
9.2% CAGR
$30Bn+
Spent annually for Food Allergy diagnosis
Lifestyle of Allergy Patients
Constant Fear
The constant fear for people with food allergies is the risk of accidental exposure leading to a severe or life-threatening allergic reaction (anaphylaxis).
-
Delayed or inadequate medical response
-
Social and lifestyle limitations
Frequent Visits
Why now?
Patients need routine visits for epinephrine auto-injectors, antihistamines, and personalized emergency action plans. Regular checkups help track allergy severity, assess immune responses, and update dietary restrictions.
Post-COVID, a sudden shift toward home-based, rapid diagnostics has encouraged diagnosis at the user's comfort and the potential to develop diagnostic tools in a newly penetrable market segment.
Our Approach
WE are approaching the problems by developing the following solutions!
01
Rapid & Portable
The current need for market adoption is for a device that does not require any laboratory dependency and can provide rapid results.
02
Easy-to-Use
The complete automation of processes for lab-accurate results, and zero-intervention and requirement of medical professional supervision.
03
Post-test Support
Interpretation of results, with integrative AI for lifestyle support to help with food habits, body fitness and enabling direct control over health for users.
04
Whole-Body Wellness
Our approach blends diagnosis and lifestyle support to improve overall health and day-to-day life.
Rapid Allergy Testing Kit
Our Proposed Solution:


Fully Autonomous, safely disposable, and electronics-free device.

Our Partners
SISFS Investor
Also incubated at
Research Partner
Academia Partner

.png)


